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Background: Preoperative airway assessment in Denmark is based on a non-specific clinical assessment left to the
discretion of the responsible anesthesiologist. The DIFFICAIR trial compares the effect of using a systematic and
consistent airway assessment versus a non-specific clinical assessment on the frequency of unanticipated difficult airway
management.
To prevent outcome bias and selective reporting, we hereby present a detailed statistical analysis plan as an amendment
(update) to the previously published protocol for the DIFFICAIR trial.
Method/Design: The DIFFICAIR trial is a stratified, parallel group, cluster (cluster = department) randomized multicenter trial
involving 28 departments of anesthesia in Denmark randomized to airway assessment either by the Simplified Airway Risk
Index (SARI) or by a usual non-specific assessment. Data from patients’ preoperative airway assessment are registered in the
Danish Anesthesia Database. An objective score for intubation grading the severity, that is the severity of the intubations, as
well as the frequency of unanticipated difficult intubation, is measured for each group.
Primary outcome measures are the fraction of unanticipated difficult and easy intubations.
The database is programmed so that the registration of the SARI is mandatory for the intervention group but invisible to
controls.
Data recruitment was commenced in October 2012 and ended in ultimo December 2013.
Conclusion: We intend to increase the transparency of the data analyses regarding the DIFFICAIR trial by an a priori
publication of a statistical analysis plan.
Trial registration: ClinicalTrials.gov: NCT01718561.
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The difficult airway management trial (DIFFICAIR) is a
stratified, parallel group, cluster (cluster = department)
randomized and multicenter trial involving 28 depart-
ments of anesthesia in Denmark. The DIFFICAIR trial
compares the effect of two regimens of preoperative
airway assessment on the frequency of unanticipated
difficult airway management.
Prediction of difficult airway management remains a
pivotal challenge in anesthesia. Difficult tracheal intubation
and difficult mask ventilation may cause serious patient
complications [1-6]. By allocating experienced personnel* Correspondence: anderskehlet@hotmail.com
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unless otherwise stated.and relevant equipment, better prediction of difficult airway
management may reduce complications and, thereby, asso-
ciated morbidity and mortality. There is no single predictor
that is sufficiently valid in predicting difficult tracheal intub-
ation [7-12]. However, several studies show that by combin-
ing multiple predictors of difficult tracheal intubation, the
positive and the negative predictive value of the assessment
increases [12]. In Denmark as well as internationally, there
is no clear recommendation on how to perform airway
assessment. Consequently, airway assessment in Denmark
is based exclusively on the individual anesthesiologist’s
preoperative clinical assessment. However, it is poorly doc-
umented how accurately this clinical assessment predicts
actual airway management conditions.
The ‘Simplified Airway Risk Index’ (SARI) [13] is based
on a multivariable model for airway assessment describedl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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the likelihood of a difficult direct laryngoscopy. The SARI
contains seven individual predictors for a difficult direct
laryngoscopy, each given a weighted score of 0 to 1 or 0 to
2. A summarized value of the SARI score > 3 indicates that
a future direct laryngoscopy will be difficult. It is unknown,
whether the SARI score predicts difficult intubation better
or worse than a clinical assessment. The rationale for this
trial was to prospectively compare the effect of the SARI
with an non-specified clinical airway assessment on the fre-
quency of unanticipated difficult airway management.
The target population was adult patients undergoing
anesthesia. Twenty-eight departments of anesthesia were
randomized to one of two groups. Intervention depart-
ments used the SARI score for preoperative airway as-
sessment. The intervention group additionally did an
assessment of risk factors for difficult mask ventilation
as described by Kheterpal and colleagues [14-16]. Depart-
ments in the control group continued normal practice of
preoperative airway assessment. All data were registered in
the Danish Anesthesia Database (DAD). A more detailed
trial protocol describing background, design and rationale
has been published in Trials [17].
In order to prevent outcome reporting bias and results
based on data-driven analysis, it is encouraged to pro-
spectively publish a trial protocol [18,19]. The same argu-
ment applies for a prospective publication of a statistical
analysis plan. Concordantly, the International Conference
on Harmonization (ICH) of Good Clinical Practice (GCP)
recommends that clinical trials are analyzed according
to a pre-specified plan [19].
Objective
The primary aim of the DIFFICAIR trial is to compare
the effect of using a systematic airway assessment with a
standard clinical airway assessment on the frequency
of unanticipated difficult airway management. The null
hypothesis is:
 There is no difference in the proportion of
unanticipated difficult intubations when the
preoperative airway assessment is based on the SARI
score compared with a preoperative airway
assessment based on the individual anesthesiologist’s
assessment.
The alternative hypothesis is:
 The use of a systematic SARI airway assessment,
registration of the SARI and risk factors for difficult
mask ventilation, and continuous education in
airway assessment will reduce the relative risk of a
difficult intubation with 30%, corresponding to a
number needed to treat (NNT) of 180 patients.Methods
This analysis plan has been written while the data collec-
tion from the DIFFICAIR trial was on-going and trial
data non-accessible. The data analysis of the main publi-
cation will follow this plan. The statistical analysis was
approved by the DIFFICAIR steering committee on 29
December 2013. The last day of data collection was 31
December 2013. The involved departments were given
one additional month to ensure registration of all patients
in the Danish Anesthesia Database. On 31 January 2014,
the database was locked and data extracted. The statistical
analysis plan was published on (www.clinicaltrials.gov)
before the last data entry and before data was extracted
and data management commenced.
The DIFFICAIR trial protocol has been written according
to the Standard Protocol Items: Recommendations for
Interventional Trials (SPIRIT) guidelines and has been
public on (www.difficair.com) since the beginning of
the trial and is registered at (www.clinicaltrials.gov)
(NCT01718561). The Danish Anesthesia Database and
the Danish Society of Anaesthesiology and Intensive
care Medicine (DASAIM) endorsed the trial.
The trial is carried out in accordance with the Helsinki
declaration. The Scientific Ethics Committee of Copenhagen
County has declared that it is regarded as a quality assur-
ance project and thus should not be reported to the com-
mittee system (Journal number: H-3-2012-FSP2). Further,
the need for individual patient consent was waived.
The trial is approved by The Danish Data Protection
Agency (Journal number: 2007-58-0015/HIH-2011-10,
I-Suite number: 02079). The reporting of the trial will
be in accordance with the CONSORT 2010 statement:
extension to cluster randomised trials [20].
Randomization and sample size
Our sample size calculation was based on an adjustment
for the stratification and the cluster randomized design
[21,22]. Since there are no previous records of the trial’s
primary outcome measure, ‘unanticipated difficult in-
tubation’ a baseline study was conducted based on data
from the DAD. In order to reject or detect a 30% rela-
tive risk reduction in the proportions of unanticipated
difficult intubation between the intervention group and
the control group approximately 30 departments were
required in a 15 months period. Calculations were based
on a maximum risk of type 1 error of 5% and risk of type
2 error of maximum 20% (80% power).
A total of 28 departments were included and randomized
1:1 using a computer generated list. The sample size
calculation was based on an average cluster size of
1,611 patients. We estimated the average cluster size
in the DIFFICAIR trial to approximately 2,500 patients,
giving a total of 70,000 included patients during the trial
period. The enhanced sample size allows for a potentially
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from 30 to potentially 26. Our sample size estimation
may be of a conservative nature, calling for more clus-
ters than necessary [23].
Populations
The DIFFICAIR trial focuses on two essential elements
of airway management which are tracheal intubation by
direct laryngoscopy and mask ventilation. This statis-
tical analysis plan will address analysis of the data re-
garding tracheal intubation. Data analysis regarding
prediction of difficult mask ventilation will be handled
in an analogous way, but will not be further elaborated
in the present paper.
The part of the DIFFICAIR trial regarding prediction
of difficult intubation comprises two populations; 1) pa-
tients that were primarily attempted intubated by direct
laryngoscopy; 2) patients that were primarily attempted
intubated by direct laryngoscopy (population 1) plus pa-
tients anticipated to be difficult to intubate and therefore
scheduled for and intubated with an advanced method
(for example, video laryngoscopic or fiber optic intubation).
The results of population 1 and 2 will be presented in
one publication. Due to the extent of data, further publi-
cations presenting data from the DIFFICAIR trial will
follow, but further elaboration on data analysis exceeds
the content frame of this paper.
Adjusting and stratification variables
Each cluster (department) was randomized to a control
or intervention group, making this the intervention group
indicator. The trial site may account for further intervention
heterogeneity and will be used for adjustment in the analysis
of the intervention effect. Further, a stratification vari-
able that grouped the departments according to whether
the proportion of unanticipated difficult intubation at
baseline was ≥ or < 2% will be used for adjustment ac-
cording to recent evidence of increased power in the
analysis of stratified trials [22].
Assumed confounding covariates
We define age; gender; ASA classification; emergency/
elective procedure; Body Mass Index (BMI); and use of
neuromuscular blocking agents as covariates that are
possible confounders, necessitating adjusted analyses of the
primary outcome and pre-defined subgroup analyses.
Primary outcomes
The primary outcome measures are:
1. The fraction of unanticipated difficult
intubations = all intubations with unanticipated
difficulties (False negative)/all patients primarily
(attempted) intubated by direct laryngoscopy.2. The fraction of unanticipated easy intubations = all
intubations with anticipated difficulties that were
easy (False Positive)/all patients primarily
(attempted) intubated by direct laryngoscopy.
The two primary outcomes are linked and simultaneous





3. The fraction of anticipated difficult intubations
planned for, and intubated by an advanced
method/all patients (attempted) intubated.
4. The fraction of unanticipated difficult intubations
(False Negative)/all difficult intubations
((False negative) + (True Positive)).
5. Sensitivity of the prediction of a difficult/easy intubation.
6. Specificity of the prediction a difficult/easy intubation.
7. Predictive value of a positive prediction of
difficult/easy intubation.
8. Predictive value of a negative prediction of
difficult/easy intubation.
9. Positive Likelihood Ratio = (Sensitivity/(1-Specificity)).
10. Negative Likelihood Ratio = ((1-Sensitivity)/Specificity).
11. The Receiver Operating Characteristic (ROC)
curve. A graphical representation of sensitivity as a
function of (1-Specificity).
Outcomes 5 to 10 are measured for both interven-
tion groups.










6. American Society of Anesthesiologists (ASA)
Classification
7. Use of neuromuscular blocking agents
8. Hospital unit
9. Region
10. Anticipated difficult tracheal intubation
11. Anticipated difficult mask ventilation
12. Scheduled airway
13. Priority: emergency/elective
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15. Intubation score




3. Modified Mallampati classification
4. Jaw protrusion
5. Neck mobility
6. Previous difficult airway management
7. Number of completed risk factors
8. The calculated SARI score
9. Dichotomized SARI score (<or ≥ 4)
10. Snoring
11. Sleep apnoea
12. Presence of beard
13. Changes in the neck due to radiation.
Cluster level summaries
1. Mean cluster size
2. Mean number of intubated patients
3. Fraction of private hospitals
4. Mean fraction of unanticipated difficult intubation




Definition of difficult intubation
In the DAD, an intubation score is programmed based on
numbers of intubation attempts and use of equipment.
1. A maximum of two intubation attempts - only by
direct laryngoscopy.
2. A maximum of two intubation attempts in which other
intubation equipment or assistive devices for direct
laryngoscopy is used (for example, video laryngoscope).
3. Three intubation attempts or more - regardless of
intubation method.
4. Intubation failed despite attempting.
Tracheal intubation by direct laryngoscopy is pre-defined
in the DAD as easy by a score = 1 and difficult by a
score ≥ 2. In our primary analyses and sample size cal-
culation we employ the same definition.
General analysis principles
1. Unless otherwise stated, all main analyses will
compare the two intervention groups using
intention-to-treat (ITT) [24].2. In order to ensure a correct type 1 error risk, all
main analyses will account for the clustered design
of the trial and the stratification variable [25-27].
Analyses will be based on individual patient level
data but clustering of patients and the stratification
variable will be accounted for in a generalized
estimating equation.
3. In all analyses, a maximum level of 5% (two-sided)
type 1 error will be regarded as statistically
significant unless otherwise stated.
4. Main analyses will be according to ITT adjusted for
cluster and stratification variables. Sensitivity
analyses will be performed adjusted and unadjusted
for the prior listed potential confounding covariates.
We will discuss if results differ from the main
analyses. The conclusion of the trial will be based on
the primary analyses.
5. Test of interaction will be applied for subgroup
analyses.
6. Risks are reported as relative risks and odds ratios.
When relative risks are calculated from odds ratios
with 95% confidence interval (CI) it will be done
according to Zhang and Yu [28].
7. For missing data exceeding a rate of 5%, and with a
statistical significant Little’s test, indicating that the
missing data is not a completely random sample of
the total data, point estimates with 95% CI will be
calculated using a worst/best case scenario
imputation on the missing values. If the imputation
of a worst/best case scenario implies different
conclusions, multiple imputations will be performed
on the missing values assuming missingness at
random [29]. Unadjusted and complete case analyses
will also be presented.
8. In order to avoid rejecting a true null hypothesis we
will address the problem of multiplicity by
Bonferroni adjustments on the secondary outcome
measures. If unadjusted analyses are insignificant
(P > 0.05), Bonferroni adjustments will not be
applied. In case the adjustment changes an
unadjusted significant P-value to a non-significant
P-value, this will be discussed.
9. To ensure complete objectivity, the author (AN) will
be blinded for the intervention group in the primary
outcome analysis and, as far as this is possible, for
analyses of secondary outcomes. However, analyses
of the predictive properties of the SARI will require
un-blinding of AN. After data collection, a third
party data manager will generate a complete dataset
with blinded coding of the intervention groups and
other variables possibly revealing the intervention.
The statistician performs the primary outcome
analysis on this data set. If the primary outcome
differs between groups, we will construct different
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significant differences of the intervention could both be
of benefit or harm. After writing the conclusions, we
will uncover the code of the blinding, and subsequently
the correct conclusion will be employed [30].
Statistical analyses
Trial profile
The flow of study participants will be displayed in a
Consolidated Standards of Reporting Trials (CONSORT)
diagram at a cluster level and at individual level. The
number of clusters fulfilling the inclusion criteria, and
the number of clusters included in primary and sec-
ondary analyses, will be presented. The number of pa-
tients who fulfilled study inclusion criteria as well as
the number included in the primary and secondary
analyses will be reported. Reasons for exclusions of
clusters and patients in the primary and secondary
analyses will be reported.
Primary outcome
Frequencies and percentages per group will be reported
with a 95% CI. The primary outcome is presented as odds
ratios and relative risk ratios.
The primary analysis of the primary outcome will be
adjusted for the stratification- and the cluster-variable
performed according to the ITT principle including
patients that met the inclusion- and not the exclusion-
criteria. A generalized estimating equation will be
used. Intervention group and stratification variable are
regarded as fixed effects and trial site is regarded as
random effects in the model. We will test the robust-
ness of the results by repeating the analyses with a
mixed effects model and finally with a standard t-test
comparing the means of the outcome at department
level in each intervention group.
The first sensitivity analysis of the primary outcome
will be adjusted for the stratification- and cluster-variables
as well as baseline covariates assumed as confounders
incorporated in a generalized estimating equation.
In the second sensitivity analysis of the primary out-
come, we will employ a different cut-off value for difficult
intubation using ≥ 3 instead of ≥ 2 as the definition of
difficult intubation.
Further sensitivity analyses of the primary outcome
will compare the patients in the control group that
met the inclusion- and not the exclusion-criteria with
patients in the intervention group who received the
protocoled intervention. That is, a per protocol ana-
lysis of control group versus the subgroup in the inter-
vention group that had a sufficiently registered SARI.
Interaction test will be performed in the intervention
group between patients receiving sufficient/insufficient
SARI registration.Secondary outcomes
Frequencies, proportions, percentages, odds and risk ratios
are presented with a 95% CI for each group. A chi-squared
test is used to assess the effect of the intervention on binary
outcomes. For categorical outcomes and the adjusted ana-
lyses, logistic regression analysis or generalized estimating
equations will be performed.
Baseline comparisons of patient characteristics
Baseline characteristics are presented for each intervention
group. Frequencies, proportions and percentages will be
used to summarize discrete variables. In case of missing
values, percentages are presented with the actual denom-
inator and otherwise calculated according to the number
of participating patients. Continuous variables are sum-
marized using standard measures of central tendency
and dispersion using either mean ± SD for data with
normal distribution or median and interquartile range
for non-normally distributed data.
Baseline comparisons of cluster characteristics
Cluster characteristics are presented for each group, control
and intervention. Unless otherwise stated, data will be
presented as means with SD for data with normal dis-
tribution or median and interquartile range for non-
normally distributed data.
Outline of figures and tables
The first figure will be a CONSORT flow chart on indi-
vidual patient level and cluster level. A second figure
will illustrate the SARI score and tutorial instruments.
A third figure will demonstrate the registration in the
DAD, including the intubation score. A fourth figure
will present baseline data from each intervention group on
individual and cluster level and a fifth figure will be outlin-
ing the main outcome results for each intervention group.
Discussion
In order to avoid outcome reporting bias and data-driven
results this paper presents the detailed statistical analysis
plan for the main publication of the DIFFICAIR trial.
The DIFFICAIR trial raises two important questions,
which are: is it possible via the intervention to reduce
the frequencies of difficult intubation and/or difficult
mask ventilation? This plan only addresses the statistical
analyses of the population of intubated patients because
our sample size calculations were based on this popula-
tion. Secondly, the SARI was developed as a prediction
tool for difficult intubation. Finally, the extent of data ne-
cessitates several publications.
By adjusting our primary outcome analysis for different
design variables, such as clustering and stratification,
we strive to eliminate inflated type 1 error rates as a
consequence of the trial design. A generalized estimating
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as having random or fixed effects [31,32].
When multiple comparisons are performed between
two groups, you may risk accepting an intervention effect
erroneously (type 1 error). There are several approaches
that deal with multiple testing. We will employ Bonferroni
adjustments on the secondary outcome measures in order
to evaluate, identify and discuss dubious significant out-
comes that may be due to statistical multiplicity.
The value of a diagnostic test is usually presented as sen-
sitivity and specificity. We have chosen (1 - total accuracy),
that is the proportion of unanticipated difficult intubations
(False Negative, FN) and the proportion of unanticipated
easy intubations (False Positive, FP). Both scenarios are of
clinical relevance since the FNs are at risk of hypoxia, in-
creased morbidity and even death, while the FPs are at risk
of being imposed unnecessary discomfort by, for example,
awake intubation. At the same time, both the FNs and FPs
can take up unnecessary resources. Sensitivity and specifi-
city are more difficult to interpret intuitively. Consequently,
we chose to present more transparent primary outcomes.
Using proportions of unanticipated difficult intubation
allowed us to perform a baseline cohort study, on which
we based our sample size and power calculations.
By publishing this paper, where we pre-specify our
methods and analyses, it is our hope that the results
from the DIFFICAIR trial will be as transparent and
robust as possible.
Conclusion
This paper presents the principles of analyses of the
main outcomes in the DIFFICAIR trial for the first pub-
lication based on patients who underwent intubation.
Our approach aims to minimize the risk of data-driven
results and outcome reporting bias.
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